Literature DB >> 1914777

Gastric "pseudolymphoma" with restricted light chain expression in a patient with obscure gastrointestinal blood loss.

H Schulman1, J Sickel, M S Kleinman, J T Adams.   

Abstract

We present a case report of a gastric "pseudolymphoma" (GL) that exhibits restricted light chain expression and, therefore, illustrates the dilemma encountered when histologically benign lesions have phenotypic abnormalities suggesting malignancy. For many years this lesion has been considered usually benign; however, recent reports such as this one demonstrate immunologic signs of monoclonality in an otherwise histologically benign lesion. This finding challenges our assumptions as to the nature of this lesion and our definition of cancer. The lesion also displays "Castleman-like" features (angiofollicular hyperplasia) as well as "common inflammatory" germinal centers. In addition we briefly review the literature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914777     DOI: 10.1007/bf01296823

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Away with leniency toward gastric pseudolymphoma.

Authors:  A Sternberg; A Koren; A Kadish; J Sandbank; R Reiss
Journal:  Arch Surg       Date:  1989-06

2.  Monoclonal small (well-differentiated) lymphocytic proliferations of the gastrointestinal tract resembling lymphoid hyperplasia: a neoplasm of uncertain malignant potential.

Authors:  J S Burke; K Sheibani; B N Nathwani; C D Winberg; H Rappaport
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

3.  Primary B cell gastric lymphoma. A genotypic analysis.

Authors:  J Spencer; T C Diss; P G Isaacson
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

4.  Gastric pseudolymphoma. A challenging clinical problem.

Authors:  R K Orr; J R Lininger; W Lawrence
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

5.  Primary gastric lymphoma and pseudolymphoma.

Authors:  S S Jung; T J Wieman; R D Lindberg
Journal:  Am Surg       Date:  1988-10       Impact factor: 0.688

6.  Pseudolymphoma of the breast. I. In a study of 8,654 consecutive tylectomies and mastectomies.

Authors:  J J Lin; G J Farha; R J Taylor
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

7.  Pseudolymphoma of the stomach. A clinicopathologic study of 15 cases.

Authors:  O Tokunaga; T Watanabe; M Morimatsu
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

8.  Lymphomas and pseudolymphomas of the alimentary tract. An immunohistochemical study with clinicopathologic correlations.

Authors:  P Saraga; J Hurlimann; L Ozzello
Journal:  Hum Pathol       Date:  1981-08       Impact factor: 3.466

9.  Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review.

Authors:  J J Brooks; H T Enterline
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

10.  Pseudolymphoma of the stomach. A diagnostic and therapeutic dilemma.

Authors:  S S Mattingly; M L Cibull; M D Ram; P F Hagihara; W O Griffen
Journal:  Arch Surg       Date:  1981-01
View more
  1 in total

Review 1.  Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.

Authors:  A P Weston; D R Campbell; D H McGregor; R Cherian
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.